Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP318391.RAi8-Bo2TN5EDexmXr7uadlyD8pqrrN9qggS8o0H3i8cY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP318391.RAi8-Bo2TN5EDexmXr7uadlyD8pqrrN9qggS8o0H3i8cY130_assertion type Assertion NP318391.RAi8-Bo2TN5EDexmXr7uadlyD8pqrrN9qggS8o0H3i8cY130_head.
- NP318391.RAi8-Bo2TN5EDexmXr7uadlyD8pqrrN9qggS8o0H3i8cY130_assertion description "[We investigated the clinical impact of the expression of PTEN, p-Akt and PI3K in HER2-positive metastatic breast cancer (MBC) patients treated with trastuzumab-based therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP318391.RAi8-Bo2TN5EDexmXr7uadlyD8pqrrN9qggS8o0H3i8cY130_provenance.
- NP318391.RAi8-Bo2TN5EDexmXr7uadlyD8pqrrN9qggS8o0H3i8cY130_assertion evidence source_evidence_literature NP318391.RAi8-Bo2TN5EDexmXr7uadlyD8pqrrN9qggS8o0H3i8cY130_provenance.
- NP318391.RAi8-Bo2TN5EDexmXr7uadlyD8pqrrN9qggS8o0H3i8cY130_assertion SIO_000772 20389136 NP318391.RAi8-Bo2TN5EDexmXr7uadlyD8pqrrN9qggS8o0H3i8cY130_provenance.
- NP318391.RAi8-Bo2TN5EDexmXr7uadlyD8pqrrN9qggS8o0H3i8cY130_assertion wasDerivedFrom befree-20140225 NP318391.RAi8-Bo2TN5EDexmXr7uadlyD8pqrrN9qggS8o0H3i8cY130_provenance.
- NP318391.RAi8-Bo2TN5EDexmXr7uadlyD8pqrrN9qggS8o0H3i8cY130_assertion wasGeneratedBy ECO_0000203 NP318391.RAi8-Bo2TN5EDexmXr7uadlyD8pqrrN9qggS8o0H3i8cY130_provenance.